Name
Osaühing FloMed
Registry code
11436640
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
25.01.2008 (16)
Financial year
01.01-31.12
Capital
2 812.00 €
Activity
86211 - Provision of general medical treatment
371 689 €
78 116 €
21%
1 838 €
(estimate is approximate)
86 031 €
4
Submitted
No tax arrears
91%
72%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Flarida Katejeva 09.03.1957 (67) | 100% - 2 812.00 EUR | Board member | Member of a higher management body, i.e. board member or supervisory board member | Founder |
| Juri Nedaškovski 30.10.1963 (61) | - | - | - | Auditor who has assessed non-monetary contribution |
| 2019 26.06.2020 | 2020 12.05.2021 | 2021 27.04.2022 | 2022 22.05.2023 | 2023 29.02.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 205 406 € | 242 509 € | 276 562 € | 312 748 € | 371 689 € |
| Net profit (loss) for the period | 37 050 € | 32 408 € | 69 852 € | 84 357 € | 78 116 € |
| Profit Margin | 18% | 13% | 25% | 27% | 21% |
| Current Assets | 39 803 € | 52 222 € | 82 944 € | 63 183 € | 90 446 € |
| Fixed Assets | 2 686 € | 9 778 € | 7 251 € | 12 197 € | 18 335 € |
| Total Assets | 42 489 € | 62 000 € | 90 195 € | 75 380 € | 108 781 € |
| Current Liabilities | 13 460 € | 14 526 € | 16 907 € | 17 735 € | 22 750 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 29 029 € | 47 474 € | 73 288 € | 57 645 € | 86 031 € |
| Employees | 3 | 3 | 3 | 3 | 4 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 13 993.97 € | 14 292.98 € | 4 |
| 2023 Q4 | - | 13 215.14 € | 13 485.64 € | 3 |
| 2023 Q3 | - | 29 978.75 € | 14 711.39 € | 5 |
| 2023 Q2 | - | 9 704.83 € | 9 772.57 € | 4 |
| 2023 Q1 | - | 11 284.62 € | 11 436.39 € | 4 |
| 2022 Q4 | - | 16 705.79 € | 9 273.65 € | 4 |
| 2022 Q3 | - | 10 777.46 € | 10 898.81 € | 4 |
| 2022 Q2 | - | 25 283.57 € | 10 816.8 € | 4 |
| 2022 Q1 | - | 9 953.96 € | 10 019.2 € | 4 |
| 2021 Q4 | - | 21 545.66 € | 12 557.81 € | 4 |
| 2021 Q3 | - | 13 848.83 € | 13 983.6 € | 4 |
| 2021 Q2 | - | 9 065.54 € | 9 106.31 € | 4 |
| 2021 Q1 | - | 8 152.09 € | 8 225.1 € | 4 |
| 2020 Q4 | - | 11 366.05 € | 9 905.99 € | 4 |
| 2020 Q3 | - | 9 252.83 € | 8 770.38 € | 4 |
| 2020 Q2 | - | 7 920.4 € | 8 071.13 € | 4 |
| 2020 Q1 | - | 10 963.92 € | 8 601.68 € | 4 |
